RE: Spodumene Price15 Aug 2024 08:27
PREM's management currently consists solely of George Roach, the CEO, who does not fulfil his role towards the shareholders in any way. The resulting lack of information and the considerable dilution of public shares could sooner or later drive the company into bankruptcy or into the hands of CANMAX. The agreed deadlines are regularly not met, which indicates that PREM will soon no longer be financially viable. A takeover by CANMAX, which is currently behaving with conspicuous restraint, seems inevitable. This decline of PREM is unfortunately at the expense of the shareholders.